Mike Gutch

Director of Finance/CFO at

Entasis Therapeutics, Inc.

60 year

62 connections

Health Technology

Finance

Consumer Services

Profile

Michael J.
Gutch is currently a Director at Southeast BIO, Albireo AB, Entasis Therapeutics Ltd., The Johns Hopkins University, and Alzheimers Drug Discovery Foundation.
He is also the Chief Financial & Business Officer at Entasis Therapeutics, Inc. since 2017.
Previously, he held positions as a Director at AstraZeneca PLC, PhaseBio Pharmaceuticals, Inc., BlinkBio, Inc., G1 Therapeutics, Inc., and Affinita Biotech, Inc. He was also an Investment Director at H.I.G.
Capital LLC from 2008 to 2011.
Additionally, he served as the CFO, Director & Chief Business Officer at Albireo Pharma, Inc. from 2015 to 2023.
He has also worked at Eli Lilly & Co., MedImmune Ventures, Inc., LV Management Group, LLC, H.I.G.
BioHealth Partners LLC, and H.I.G.
Ventures LLC.
Dr. Gutch holds a doctorate degree from Stony Brook University, an MBA from Indiana University, and an undergraduate degree from Alfred University.

Mike Gutch active positions

Companies	Position	Start
Southeast BIO	Director/Board Member	-
Alzheimers Drug Discovery Foundation Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology Operates as a research organisation	Corporate Officer/Principal	-
The Johns Hopkins University The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Albireo AB Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders	Director/Board Member	-
Entasis Therapeutics, Inc. Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases	Director of Finance/CFO	2017-04-10
Entasis Therapeutics Ltd. Entasis Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Director/Board Member	2018-04-22

All active positions of Mike Gutch

Former positions of Mike Gutch

Companies	Position	End
Noema Pharma AG Noema Pharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that provide therapeutics for central nervous system	Director of Finance/CFO	2025-01-07
ALBIREO PHARMA, INC.	Director of Finance/CFO	-
ENTASIS THERAPEUTICS HOLDINGS INC.	Director of Finance/CFO	2022-02-23
░░░░░░░░░░░ ░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░

See the detail of Mike Gutch's experience

Training of Mike Gutch

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mike Gutch's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	24
Eli Lilly & Co. Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products	Health Technology
AstraZeneca PLC AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
PhaseBio Pharmaceuticals, Inc. PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases	Health Technology
MedImmune Ventures, Inc. MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures invests in private biotechnology companies located across the globe primarily in North America. The firm focuses on healthcare sectors such as molecules, vaccines, pharmaceutical technologies, medical devices, diagnostics, imaging and healthcare IT. The firm provides financing for seed, early, later and mezzanine stage capital requirements with an investment size ranging from USD 5 - USD 10 million per round. It acts as a lead investor and takes an active role on the board of directors.	Finance
BlinkBio, Inc. BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology Develops orally active drugs that act like small drug molecules	Health Technology
H.I.G. Capital LLC H.I.G. Capital LLC Financial ConglomeratesFinance Operates as an alternative investment firm	Finance
H.I.G. Ventures LLC H.I.G. Ventures LLC Investment ManagersFinance Functions as an alternative investment manager	Finance
Stony Brook University Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
LV Management Group, LLC LV Management Group, LLC Investment ManagersFinance Lilly Ventures invests in companies located in the European regions and North America, primarily in the United States. The firm target companies operating in the fields of life sciences, biotechnology, medical technology and healthcare information technology sectors. It provides financing for early stage capital requirements.	Finance
Indiana University Indiana University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The Johns Hopkins University The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alfred University Alfred University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Southeast BIO
Alzheimers Drug Discovery Foundation Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology Operates as a research organisation	Health Technology
Albireo Ltd. Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area	Health Technology
Albireo AB Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders	Health Technology
H.I.G. BioHealth Partners LLC H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners invests in companies located in the United States. The firm targets companies operating in the field of medical devices, biopharmaceuticals, digital health, tool & diagnostics and product related services. It provides financing for acquisition, IPO and growth stage capital requirements in the form of equity and debt. It also makes follow on investments.	Finance
G1 Therapeutics, Inc. G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment	Health Technology
Entasis Therapeutics, Inc. Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases	Health Technology
Affinita Biotech, Inc. Affinita Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceuticals and biotechnology	Commercial Services
Albireo Pharma, Inc. Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders	Health Technology
Entasis Therapeutics Holdings, Inc. Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products	Commercial Services
Entasis Therapeutics Ltd. Entasis Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Health Technology
Noema Pharma AG Noema Pharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that provide therapeutics for central nervous system	Commercial Services

See company connections